scholarly article | Q13442814 |
P819 | ADS bibcode | 1995PNAS...92.2413R |
P356 | DOI | 10.1073/PNAS.92.6.2413 |
P932 | PMC publication ID | 42494 |
P698 | PubMed publication ID | 7892281 |
P5875 | ResearchGate publication ID | 15307510 |
P50 | author | Hal E. Broxmeyer | Q51754776 |
P2093 | author name string | M Horie | |
G Risdon | |||
J Gaddy | |||
P2860 | cites work | Cloning of B7-2: a CTLA-4 Counter-Receptor That Costimulates Human T Cell Proliferation | Q24311763 |
Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells | Q33858964 | ||
Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling | Q34668125 | ||
Differentiation of T cell lymphokine gene expression: the in vitro acquisition of T cell memory | Q36229797 | ||
Induction of specific nonresponsiveness in unprimed human T cells by anti-CD3 antibody and alloantigen | Q36354126 | ||
Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1 | Q36361179 | ||
B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance | Q36362561 | ||
The combination of anti-B7 monoclonal antibody and cyclosporin A induces alloantigen-specific anergy during a primary mixed lymphocyte reaction. | Q36362769 | ||
Umbilical cord blood hematopoietic stem and repopulating cells in human clinical transplantation | Q36521460 | ||
B70 antigen is a second ligand for CTLA-4 and CD28 | Q36697598 | ||
Synergy between cyclosporin A and a monoclonal antibody to B7 in blocking alloantigen-induced T-cell activation. | Q41507517 | ||
CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes | Q41642278 | ||
Allorecognition of HLA-DR and -DQ transfectants by human CD45RA and CD45R0 CD4 T cells: repertoire analysis and activation requirements | Q41708142 | ||
Transplantation of umbilical cord blood after myeloablative therapy: analysis of engraftment | Q43676721 | ||
CD28- T lymphocytes. Antigenic and functional properties. | Q52065463 | ||
Alloantigen-specific T suppressor-inducer and T suppressor-effector cells can be activated despite blocking the IL-2 receptor. | Q52107072 | ||
HLA-mismatched cord-blood transplantation in a patient with advanced leukemia | Q68124648 | ||
Tolerance of T-cell clones is associated with membrane antigen changes | Q70258947 | ||
Activation of cord T lymphocytes. III. Role of LFA-1/ICAM-1 and CD2/LFA-3 adhesion molecules in CD3-induced proliferative response | Q72080801 | ||
Umbilical cord blood transplantation: overview of the clinical experience | Q72233955 | ||
The use of umbilical cord blood in mismatched related and unrelated hemopoietic stem cell transplantation | Q72233979 | ||
Proliferative and cytotoxic responses of human cord blood T lymphocytes following allogeneic stimulation | Q72269722 | ||
Brief report: correction of X-linked lymphoproliferative disease by transplantation of cord-blood stem cells | Q72585333 | ||
Haemopoietic stem/progenitor cell transplant in Fanconi anaemia using HLA-matched sibling umbilical cord blood cells | Q72663506 | ||
Umbilical cord blood transplantation in a patient with Philadelphia chromosome-positive chronic myeloid leukemia | Q72892081 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P1104 | number of pages | 5 | |
P304 | page(s) | 2413-2417 | |
P577 | publication date | 1995-03-01 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Alloantigen priming induces a state of unresponsiveness in human umbilical cord blood T cells | |
P478 | volume | 92 |
Q33819935 | 4-1BB and CD28 signaling plays a synergistic role in redirecting umbilical cord blood T cells against B-cell malignancies |
Q36476061 | Alloantigen-induced unresponsiveness in cord blood T lymphocytes is associated with defective activation of Ras. |
Q37769912 | Alloreactivity from human viral specific memory T-cells |
Q73822484 | Alloreactivity of umbilical cord blood mononuclear cells: specific hyporesponse to noninherited maternal antigens |
Q77711894 | Alloresponses of cord blood cells in primary mixed lymphocyte cultures |
Q54778744 | Amplification of T cells from human cord blood in serum-deprived culture stimulated with stem cell factor, interleukin-7 and interleukin-2. |
Q74074329 | Analysis of neonatal T cell and antigen presenting cell functions |
Q44606441 | Association of CD26 with CD45RA outside lipid rafts attenuates cord blood T-cell activation |
Q59640188 | CD34+ progenitors are reproducibly recovered in thawed umbilical grafts and positively influence haematopoietic reconstitution after transplantation |
Q73128939 | CD40-deficient dendritic cells producing interleukin-10, but not interleukin-12, induce T-cell hyporesponsiveness in vitro and prevent acute allograft rejection |
Q33922377 | Can cord blood cells support the cytokine storm in GvHD? |
Q74082601 | Characterization of the T cell receptor repertoire of neonatal T cells by RT-PCR and single strand conformation polymorphism analysis |
Q40639431 | Cord blood serum affects T cells ability to produce and respond to IL-2. |
Q37096984 | Cord blood stem cell transplantation for haemoglobinopathies |
Q45876292 | Cord blood transplantation and the potential for gene therapy. Gene transduction using a recombinant adeno-associated viral vector. |
Q43662440 | Cyclosporin A effects during primary and secondary activation of human umbilical cord blood T lymphocytes |
Q47901481 | Cytokine-enhanced mixed lymphocyte reaction (MLR) in cord blood |
Q30479628 | Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posttransplantation adoptive immunotherapy |
Q44583955 | Distinctive response of naïve lymphocytes from cord blood to primary activation via TCR. |
Q43761355 | Effect of interleukin (IL)-12 and IL-15 on apoptosis and proliferation of umbilical cord blood mononuclear cells |
Q36681962 | Ex vivo expansion of umbilical cord blood stem cells for transplantation: growing knowledge from the hematopoietic niche |
Q42528087 | Ex vivo isolation protocols differentially affect the phenotype of human CD4+ T cells |
Q40855783 | Generation of HLA-A2 subtype specific cytotoxic T lymphocytes from cord blood used for cord blood stem cell transplantation |
Q35674530 | Hematopoietic stem cell transplantation using umbilical cord blood progenitors: review of current clinical results |
Q40725991 | Human leucocyte antigen-Cw-specific cytotoxic T lymphocytes generated from naive cord blood used for cord blood stem cell transplantation |
Q73399817 | Immune reconstitution and outcome after unrelated cord blood transplantation: a single paediatric institution experience |
Q39440909 | Infectious pathogens may trigger specific allo-HLA reactivity via multiple mechanisms. |
Q74140153 | Intracellular cytokine profile of cord and adult blood monocytes |
Q52103692 | Maturation of adult peripheral blood CD38(+)CD4(+) T cells demonstrated by cytokine production in response to a superantigen, TSST-1. |
Q34332344 | Neonatal infectious diseases: evaluation of neonatal sepsis |
Q44157136 | Ontogenic changes in CD95 expression on human leukocytes: prevalence of T-cells expressing activation markers and identification of CD95-CD45RO+ T-cells in the fetus |
Q77135882 | Phenotypic and functional comparison of monocytes from cord blood and granulocyte colony-stimulating factor-mobilized apheresis products |
Q74813033 | Phenotypic characteristics of cord blood hemopoietic cells |
Q44075409 | Reduced CTLA-4 protein and messenger RNA expression in umbilical cord blood T lymphocytes. |
Q34263277 | Status of umbilical cord blood transplantation in the year 2001. |
Q35692623 | Stem cell transplantation in the fetus |
Q43622949 | Study of cord blood natural killer cell suppressor activity. |
Q37946397 | The developing immune system - from foetus to toddler |
Q41470967 | Umbilical cord blood stem cells: application for the treatment of patients with hemoglobinopathies |
Search more.